Indoco Remedies

Update in progress

INDOCO.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Indoco Remedies Limited manufactures and markets pharmaceutical formulations and active ingredients for global customers. Its portfolio covers GI, anti-infectives, respiratory, dental, vitamins and minerals, urology, ophthalmology, dermatology, pain, cardiovascular, diabetes and gynecology. It offers branded generics, analytical and contract research services, and engineering and project management services. Founded in 1945, it is based in Mumbai, India.

Company score

Sentiment: 0.20; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.16; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.03; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.13; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive